BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28140329)

  • 1. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
    Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
    Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H; Weng J; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
    Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
    Nayeem MA; Geldenhuys WJ; Hanif A
    Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
    Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
    Fleming I
    Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
    Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
    PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
    Imig JD
    Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
    Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
    Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
    J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
    Shi Z; He Z; Wang DW
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-dependent eicosanoid production and crosstalk.
    Fleming I
    Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
    Tauber Z; Koleckova M; Cizkova K
    Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.